单剂新型嵌合亚单位疫苗E2-CD154对古典猪瘟病毒提供早期完全保护
本研究利用慢病毒载体构建稳定表达E2-CSFV抗原与猪CD154融合蛋白的HEK293细胞系,E2-CD154嵌合蛋白在悬浮培养中分泌浓度约50mg/L。动物单剂免疫后7天以高毒力CSFV攻毒,无临床症状;攻毒后8天(免疫后14天)诱导特异性中和抗体和IFN-γ。首次报告单次免疫后第一周内即获完全保护的亚单位疫苗。
要点
- E2-CD154嵌合蛋白在HEK293悬浮培养中分泌浓度约50mg/L。
- 单剂免疫后7天攻毒,动物无古典猪瘟临床症状。
- 攻毒后8天(免疫后14天)诱导特异性中和抗体和IFN-γ。
核心结论
- E2-CD154亚单位疫苗单次免疫后第一周内即可提供完全保护,为首次报道。
- E2-CD154抗原可能用于疫情暴发条件下阻止CSFV传播及地方性流行区根除计划。
研究设计与样本
- 研究利用慢病毒基因递送系统获得稳定表达E2-CSFV抗原与猪CD154融合蛋白的HEK293细胞系。
- E2-CD154嵌合蛋白在悬浮培养条件下分泌至培养基,浓度约50mg/L。
- 动物免疫单剂E2-CD154后7天,以高毒力CSF病毒株攻毒。
主要发现
- 免疫动物攻毒后无古典猪瘟临床症状。
- 攻毒后8天(免疫后14天)诱导特异性抗CSFV中和抗体和IFN-γ。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Classical swine fever is an economically important, highly contagious disease of swine worldwide. Subunit vaccines are a suitable alternative for the control of classical swine fever. However, such vaccines have as the main drawback the relatively long period of time required to induce a protective response, which hampers their use under outbreak conditions. In this work, a lentivirus-based gene delivery system is used to obtain a stable recombinant HEK 293 cell line for the expression of E2-CSFV antigen fused to porcine CD154 as immunostimulant molecule. The E2-CD154 chimeric protein was secreted into the medium by HEK293 cells in a concentration around 50mg/L in suspension culture conditions using spinner bottles. The E2-CD154 immunized animals were able to overcome the challenge with a high virulent CSF virus strain performed 7days after a unique dose of the vaccine without clinical manifestations of the disease. Specific anti-CSFV neutralizing antibodies and IFN-γ were induced 8days after challenge equivalent to 14days post-vaccination. The present work constitutes the first report of a subunit vaccine able to confer complete protection by the end of the first week after a single vaccination. These results suggest that the E2-CD154 antigen could be potentially used under outbreak conditions to stop CSFV spread and for eradication programs in CSF enzootic areas.
引用
- Suárez M, Sordo Y, Prieto Y, et al. A single dose of the novel chimeric subunit vaccine E2-CD154 confers early full protection against classical swine fever virus. Vaccine. 2017. PMID: 28688785. doi:10.1016/j.vaccine.2017.05.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。